Pliant Therapeutics Inc. (NASDAQ: PLRX) will present data from its Phase 1 clinical trial of PLN-101095 at the American Association ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE